Cargando…

Ca(2+)/Calmodulin-Dependent Protein Kinase II Regulation by Inhibitor of RIPK3 Protects against Cardiac Hypertrophy

The activity of Ca(2+)/calmodulin-dependent protein kinase II δ (CaMKII δ) is central to the mechanisms of cardiovascular diseases. Receptor-interacting protein kinase 3- (RIPK3-) mediated necroptosis has been reported to contribute to cardiac dysfunction. However, the potential protective role of i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jingjing, Qian, Jianan, Cao, Ji, Wang, Xue, Zhang, Wei, Gu, Xiaosong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423983/ https://www.ncbi.nlm.nih.gov/pubmed/36046685 http://dx.doi.org/10.1155/2022/7941374

Ejemplares similares

Ca(2+)/Calmodulin-Dependent Protein Kinase II Regulation by RIPK3 Alleviates Necroptosis in Transverse Arch Constriction-Induced Heart Failure
por: Cao, Ji, et al.
Publicado: (2022)

Ca(2+)/Calmodulin-Dependent Protein Kinase II Regulation by Inhibitor of Receptor Interacting Protein Kinase 3 Alleviates Necroptosis in Glycation End Products-Induced Cardiomyocytes Injury
por: Hua, Yuyun, et al.
Publicado: (2022)

The role of Ca(2+)/calmodulin-dependent protein kinase II and calcineurin in TNF-α-induced myocardial hypertrophy
por: Wang, Gui-Jun, et al.
Publicado: (2012)

The Regulatory Effect of Receptor-Interacting Protein Kinase 3 on CaMKIIδ in TAC-Induced Myocardial Hypertrophy
por: Qian, Jianan, et al.
Publicado: (2023)

Empagliflozin Inhibits Cardiac Late Sodium Current by Ca/Calmodulin-Dependent Kinase II
por: Mustroph, Julian, et al.
Publicado: (2022)

Ca2+/calmodulin‐dependent protein kinase II and protein kinase G oxidation contributes to impaired sarcomeric proteins in hypertrophy model
por: Gömöri, Kamilla, et al.
Publicado: (2022)

Ca(2+)/Calmodulin-Dependent Protein Kinase II and Androgen Signaling Pathways Modulate MEF2 Activity in Testosterone-Induced Cardiac Myocyte Hypertrophy
por: Duran, Javier, et al.
Publicado: (2017)

Biophysical analysis of the dynamics of calmodulin interactions with neurogranin and Ca(2+)/calmodulin‐dependent kinase II
por: Seeger, Christian, et al.
Publicado: (2017)

Inhibition of TRPP3 by calmodulin through Ca(2+)/calmodulin-dependent protein kinase II
por: Liu, Xiong, et al.
Publicado: (2023)

Metabolic regulation of apoptosis via Ca+/Calmodulin Kinase II (CaMKII)
por: McCoy, Francis, et al.
Publicado: (2012)

Lobe-specific Functions of Ca(2+)·Calmodulin in αCa(2+)·Calmodulin-dependent Protein Kinase II Activation
por: Jama, Abdirahman M., et al.
Publicado: (2011)

Advances in RIPK1 kinase inhibitors
por: Chen, Lu, et al.
Publicado: (2022)

Effects of Wenxin Keli on Cardiac Hypertrophy and Arrhythmia via Regulation of the Calcium/Calmodulin Dependent Kinase II Signaling Pathway
por: Yang, Xinyu, et al.
Publicado: (2017)

A Dynamic Model of Interactions of Ca(2+), Calmodulin, and Catalytic Subunits of Ca(2+)/Calmodulin-Dependent Protein Kinase II
por: Pepke, Shirley, et al.
Publicado: (2010)

Ca(2+)/calmodulin-dependent Protein Kinases in Leukemia Development
por: Cui, Changhao, et al.
Publicado: (2021)

Erratum: Advances in RIPK1 kinase inhibitors
Publicado: (2023)

Interaction between Calcineurin and Ca(2+)/Calmodulin Kinase-II in Modulating Cellular Functions
por: Kubokawa, Manabu, et al.
Publicado: (2011)

Empagliflozin reduces Ca/calmodulin‐dependent kinase II activity in isolated ventricular cardiomyocytes
por: Mustroph, Julian, et al.
Publicado: (2018)

Mechanisms of Ca(2+)/calmodulin-dependent kinase II activation in single dendritic spines
por: Chang, Jui-Yun, et al.
Publicado: (2019)

Ca(2+/)Calmodulin-dependent kinase II delta B is essential for cardiomyocyte hypertrophy and complement gene expression after LPS and HSP60 stimulation in vitro
por: Cruz Junho, C.V., et al.
Publicado: (2019)

Molecular mechanism of activation-triggered subunit exchange in Ca(2+)/calmodulin-dependent protein kinase II
por: Bhattacharyya, Moitrayee, et al.
Publicado: (2016)

FKBP12.6 protects heart from AngII‐induced hypertrophy through inhibiting Ca(2+)/calmodulin‐mediated signalling pathways in vivo and in vitro
por: Xiao, Yun‐Fei, et al.
Publicado: (2018)

The oral Ca/calmodulin‐dependent kinase II inhibitor RA608 improves contractile function and prevents arrhythmias in heart failure
por: Mustroph, Julian, et al.
Publicado: (2020)

Structural features of Ca2+/calmodulin-dependent protein kinase II revealed by electron microscopy
Publicado: (1991)

Activation State-Dependent Substrate Gating in Ca(2+)/Calmodulin-Dependent Protein Kinase II
por: Johnson, D. E., et al.
Publicado: (2017)

Ca(2+)/Calmodulin-Dependent Protein Kinase II (CaMKII) Activity and Sinoatrial Nodal Pacemaker Cell Energetics
por: Yaniv, Yael, et al.
Publicado: (2013)

Ca(2+)/Calmodulin and Apo-Calmodulin Both Bind to and Enhance the Tyrosine Kinase Activity of c-Src
por: Stateva, Silviya R., et al.
Publicado: (2015)

Tale of two kinases: Protein kinase A and Ca(2+)/calmodulin-dependent protein kinase II in pre-diabetic cardiomyopathy
por: Gaitán-González, Pamela, et al.
Publicado: (2021)

Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors
por: Canning, Peter, et al.
Publicado: (2015)

Ca(2+)/calmodulin kinase II–dependent regulation of β(IV)-spectrin modulates cardiac fibroblast gene expression, proliferation, and contractility
por: Nassal, Drew M., et al.
Publicado: (2021)

Effects and potential mechanism of Ca(2+)/calmodulin-dependent protein kinase II pathway inhibitor KN93 on the development of ovarian follicle
por: Yu, Jianjie, et al.
Publicado: (2022)

Paeoniflorin, the Main Active Ingredient of Shuyu Capsule, Inhibits Ca(v)1.2 and Regulates Calmodulin/Calmodulin-Dependent Protein Kinase II Signalling
por: Song, Chunhong, et al.
Publicado: (2017)

Investigating the role of Ca(2+)/calmodulin-dependent protein kinase II in the survival of retinal ganglion cells
por: Guo, Xinzheng, et al.
Publicado: (2021)

Intracellular Ca(2+) and Ca(2+)/Calmodulin-Dependent Kinase II Mediate Acute Potentiation of Neurotransmitter Release by Neurotrophin-3
por: He, Xiang-ping, et al.
Publicado: (2000)

Calcium/Calmodulin–Dependent Protein Kinase II in Cerebrovascular Diseases
por: Zhang, Xuejing, et al.
Publicado: (2021)

Ca(2+)/Calmodulin-Dependent Protein Kinase II (CaMKII) Increases Small-Conductance Ca(2+)-Activated K(+) Current in Patients with Chronic Atrial Fibrillation
por: Fan, Xuehui, et al.
Publicado: (2018)

Function of calmodulin in postsynaptic densities. II. Presence of a calmodulin- activatable protein kinase activity
por: Grab, DJ, et al.
Publicado: (1981)

Assemblies of calcium/calmodulin-dependent kinase II with actin and their dynamic regulation by calmodulin in dendritic spines
por: Wang, Qian, et al.
Publicado: (2019)

Calcium/calmodulin-dependent kinase II and Alzheimer’s disease
por: Ghosh, Anshua, et al.
Publicado: (2015)

Inhibitor 1 of Protein Phosphatase 1 Regulates Ca(2+)/Calmodulin-Dependent Protein Kinase II to Alleviate Oxidative Stress in Hypoxia-Reoxygenation Injury of Cardiomyocytes
por: Luo, Huiqin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_katbcqctq38vdi19dhbl2k43p4